| |
Overview of ongoing activity of
working group on RBDs |
|
Co-chairs |
| |
RBDs in the USA ( US working group
on RBDs) |
| |
A. Shapiro (USA) |
| |
Glanzmann thrombasthenia: World
distribution, mutations and founder effects |
|
U. Seligsohn
(Israel) |
| |
Menorrhagia in women affected
by RBDs. Proposal of an International study |
| |
F. Peyvandi
(Italy) |
| |
Long term prophylaxis in afibrinogenemic patients: a rationale
based on results from single dose PK
|
|
T. Waegemans
(France) |
| |
Getting products to patients:
industry options |
| |
J. Lloyd (UK) |
| |
General discussion: future directions
|
| |
|
| |
minute
 |
